Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gold

Showing results (1011-1020 of 1,272) with videos related to

Pageof 128
Sort By:
BMJ Open|December 2, 2020
Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trialChristian Otte, Woo Ri Chae, Jan Nowacki, et al.
Biological Psychiatry|December 15, 2010
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophreniaRobert W Buchanan, Richard S E Keefe, Jeffrey A Lieberman, et al.
Schizophrenia Research. Cognition|December 14, 2019
The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measuresMichael S Kraus, James M Gold, Deanna M Barch, et al.
Schizophrenia Bulletin|September 13, 2015
Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in SchizophreniaRichard S E Keefe, George M Haig, Stephen R Marder, et al.
JAMA Psychiatry|June 4, 2025
Simvastatin as Add-On Treatment to Escitalopram in Patients With Major Depression and Obesity: A Randomized Clinical TrialChristian Otte, Woo Ri Chae, Deniz Yildirim Dogan, et al.
Pediatric Quality & Safety|September 20, 2018
Optimizing a Nurse-led Transitional Home Visit Program in Preparation for a Randomized Control TrialHadley S Sauers-Ford, Heather Tubbs-Cooley, Angela M Statile, et al.
The Lancet. Digital Health|September 29, 2023
Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trialStefan M Gold, Tim Friede, Björn Meyer, et al.
Nature Immunology|January 16, 2026
A GDF-15-GFRAL axis controls autoimmune T cell responses during neuroinflammationJana K Sonner, Audrey Kahn, Lars Binkle-Ladisch, et al.
Phytopathology|May 28, 2025
Opportunities and Challenges in Combining Optical Sensing and Epidemiological ModelingAlexey Mikaberidze, C D Cruz, Ayalsew Zerihun, et al.
Physical Review Letters|November 7, 2025
First Event-by-Event Identification of Cherenkov Radiation from Sub-Mev Particles in Liquid ArgonA A Aguilar-Arevalo, S Biedron, J Boissevain, et al.
Pageof 128

Showing results (1011-1020 of 1,272) with videos related to

Sort By:
Pageof 128
BMJ Open|December 2, 2020
Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trialChristian Otte, Woo Ri Chae, Jan Nowacki, et al.
Biological Psychiatry|December 15, 2010
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophreniaRobert W Buchanan, Richard S E Keefe, Jeffrey A Lieberman, et al.
Schizophrenia Research. Cognition|December 14, 2019
The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measuresMichael S Kraus, James M Gold, Deanna M Barch, et al.
Schizophrenia Bulletin|September 13, 2015
Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in SchizophreniaRichard S E Keefe, George M Haig, Stephen R Marder, et al.
JAMA Psychiatry|June 4, 2025
Simvastatin as Add-On Treatment to Escitalopram in Patients With Major Depression and Obesity: A Randomized Clinical TrialChristian Otte, Woo Ri Chae, Deniz Yildirim Dogan, et al.
Pediatric Quality & Safety|September 20, 2018
Optimizing a Nurse-led Transitional Home Visit Program in Preparation for a Randomized Control TrialHadley S Sauers-Ford, Heather Tubbs-Cooley, Angela M Statile, et al.
The Lancet. Digital Health|September 29, 2023
Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trialStefan M Gold, Tim Friede, Björn Meyer, et al.
Nature Immunology|January 16, 2026
A GDF-15-GFRAL axis controls autoimmune T cell responses during neuroinflammationJana K Sonner, Audrey Kahn, Lars Binkle-Ladisch, et al.
Phytopathology|May 28, 2025
Opportunities and Challenges in Combining Optical Sensing and Epidemiological ModelingAlexey Mikaberidze, C D Cruz, Ayalsew Zerihun, et al.
Physical Review Letters|November 7, 2025
First Event-by-Event Identification of Cherenkov Radiation from Sub-Mev Particles in Liquid ArgonA A Aguilar-Arevalo, S Biedron, J Boissevain, et al.
Pageof 128